Ignacy Tkaczyk

Mr. Ignacy Tkaczyk


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
PNPaulina Nazaruk
Paulina Nazaruk
ITIgnacy Tkaczyk
Ignacy Tkaczyk
MMMarta Paulina Monticolo
Marta Paulina Monticolo
AJAnna Maria Jędrzejczak
Anna Maria Jędrzejczak
NKNatalia Krata
Natalia Krata
KMKrzysztof Mucha
Krzysztof Mucha
Immunization against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has significantly limited the spread of coronavirus disease 2019 (COVID-19) and reduced the associated complications, especially mortality. To prolong immunity, an immune booster was implemented. We evaluated the role of SARS-CoV-2 infection history in the vaccination schedules of kidney and liver transplant recipients and patients with chronic kidney disease (CKD). To this end, we retrospectively analyzed the data of 78 solid organ transplantation (SOT) recipients and 40 patients with immunoglobulin A (IgA) nephropathy as representatives of the CKD group. Patients received two or three doses of the BNT162b2 vaccine. At the follow-up, antibody (Ab) titer, graft function, COVID-19 history, and patients’ clinical condition were assessed. Ab level was higher after two doses in patients with a COVID-19 history over three doses in patients with no COVID-19 history. Compared to three doses, subjects who were administered two doses had a longer median time to infection. Positive antibodies, in response to the third dose, were not observed in up to 8.4% of SOT patients. The results show that the vaccination schedule should take into account the vaccine response rate and COVID-19 history. So-called hybrid immunity appears to be most efficient at providing humoral responses against SARS-CoV-2 infection in immunocompromised patients.

6 March 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
AWAgata Wiklińska
Agata Wiklińska
JSJakub Szydło
Jakub Szydło
ITIgnacy Tkaczyk
Ignacy Tkaczyk
KRKatarzyna Rybacka-Tkaczyk
Katarzyna Rybacka-Tkaczyk
Introduction and aim of study: Depressive disorder is one of the most common diseases involving mental health. It is known as a stress-dependent disease. It triggers a number of mechanisms, which are supposed to ensure homeostasis to the body. However, under prolonged stress, they become harmful to the organism, causing a number of somatic diseases. The aim of this paper was to discuss the cause-effect relationship between depression and somatic comorbidities. Materials and methods: Databases such as PubMed and Google Scholar were searched to review the scientific literature on the association between depression and somatic comorbidities. The following keywords were used for the search: depression, somatic diseases, inflammation, HPA axis and lifestyle. Results: A review of the literature showed an increased prevalence of cardiovascular diseases, obesity, diabetes, infections and cancer among patients with depressive disorder. The most important processes underlying these correlations were: hyperactivity of the HPA axis, hyperactivity of the sympathetic nervous system and inflammation. Conclusion: In patients suffering from depression, attention should be paid to the increased incidence of somatic diseases. Both oncological and internal medicine vigilance should be increased in the treatment.